Sort
64,565 grants matching “drug discovery”
Neuroprotection in Stroke Drug Development
$1,070,000Ruben J. Boado · Armagen Technologies, Inc. · R44 · FY2006 · NS
Optimizing Novel Dihydroorotate Dehydrogenase Inhibitors for Treating Malaria
$1,069,709Ian Cyril Bathurst · Medicines For Malaria Venture · U01 · FY2008 · AI
Novel oxadiazols for the treatment of drug-resistant gram-positive bacteria
$1,069,649Mayland F Chang · University Of Notre Dame · R01 · FY2010 · AI
2/2-Rare Bipolar Loci Identification Through Synaptome Sequencing.
$1,069,587William Richard McCombie · Cold Spring Harbor Laboratory · R01 · FY2012 · MH
Aging, Oxidative Stress and Cell Death
$1,069,269Brian A. Herman · University Of Texas Hlth Science Center · P01 · FY2009 · AG
EFRI-CBE Topic B: Biofunctionalized Devices - On Chip Signaling and "Rewiring" Bacterial Cell-Cell Communication
$1,068,844William E Bentley · University Of Maryland, College Park · · FY2010 · ENG
Brain Glycogen-Metabolism,Mechanisms, and Therapeutic Potential
$1,068,798Matthew S. Gentry · University Of Florida · R35 · FY2025 · NS
A new high-throughput gastrointestinal tract explant platform for drug formulation discovery and metabolic disease modulation
$1,068,674Robert S Langer · Massachusetts Institute Of Technology · R01 · FY2021 · EB
Development of mGluR5 Antagonists to Treat Fragile X Syndrome and Autism
$1,068,100Randall L Carpenter · Seaside Therapeutics, Llc · U01 · FY2009 · MH
Development of mGluR5 Antagonists to Treat Fragile X Syndrome and Autism
$1,068,100Randall L Carpenter · Seaside Therapeutics, Llc · U01 · FY2008 · MH
Discovery and Translational Core Services
$1,068,010Gerald A Beltz · Harvard Medical School · U19 · FY2014 · AI
Structure, mechanism, and pharmacology of BRAF and its partners in the RAS/RAF/MAP kinase pathway
$1,068,000Michael J Eck · Dana-Farber Cancer Inst · R35 · FY2021 · CA
Structure, mechanism, and pharmacology of BRAF and its partners in the RAS/RAF/MAP kinase pathway
$1,068,000Michael J Eck · Dana-Farber Cancer Inst · R35 · FY2025 · CA
Structure, mechanism, and pharmacology of BRAF and its partners in the RAS/RAF/MAP kinase pathway
$1,068,000Michael J Eck · Dana-Farber Cancer Inst · R35 · FY2020 · CA
Discovering mechanisms of neuroblastoma tumorigenesis to improve patient outcomes
$1,068,000John M Maris · Children'S Hosp Of Philadelphia · R35 · FY2025 · CA
Discovery of cGAS-like signaling enzymes in innate immunity and disease
$1,068,000Philip J Kranzusch · Dana-Farber Cancer Inst · DP2 · FY2024 · GM
Structure, mechanism, and pharmacology of BRAF and its partners in the RAS/RAF/MAP kinase pathway
$1,068,000Michael J Eck · Dana-Farber Cancer Inst · R35 · FY2019 · CA
Advanced Mass Spectrometry Facility
$1,067,912David Anderson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2010 · DK
Vaccines and Therapeutics for Nipah and Hendra virus
$1,067,628Christopher Broder · Henry M. Jackson Fdn For The Adv Mil/Med · U01 · FY2011 · AI
Antidotes to Anthrax Lethal Factor Intoxication
$1,067,549Alan Thomas Johnson · Panthera Biopharma, Llc · U01 · FY2009 · AI
Molecular Targets Phase III CoBRE
$1,067,488Donald M Miller · University Of Louisville · P30 · FY2015 · GM
Structure and Function of Neurotransmitter Transporters
$1,067,481Harel Weinstein · Weill Medical Coll Of Cornell Univ · P01 · FY2009 · DA
Vascular remodeling in patients with rare genetic disorders
$1,067,418Manfred Boehm · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Development Of Theoretical Methods For Studying Biological Macromolecules
$1,067,238Bernard R Brooks · National Heart, Lung, And Blood Institute · ZIA · FY2020 · HL
Antisense Oligonucleotide (ASO) Development for Rare and Neglected Diseases
$1,066,904Elizabeth Ottinger · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR